Sinovac Determines Trigger Event Occurred Under Rights Agreement
BEIJING--(BUSINESS WIRE)--Feb 22, 2019--Sinovac Biotech Ltd. (NASDAQ: SVA) ("Sinovac" or the "Company"), a leading provider of biopharmaceutical products in China, today announced…
BEIJING--(BUSINESS WIRE)--Feb 22, 2019--Sinovac Biotech Ltd. (NASDAQ: SVA) ("Sinovac" or the "Company"), a leading provider of biopharmaceutical products in China, today announced…